- Global Investment and Multi-Asset Strategist
- About Us
- My Account
China fixed income: Dislocations create opportunities in this large and diverse market
Hear from our experts as they uncover new fixed income opportunities in China.
Investing at the biopharma frontier
Rebecca Sykes details groundbreaking innovations happening today in the biopharmaceutical industry. She explains key advancements and the investment landscape for therapies targeting diabetes, cancer, and Alzheimer's disease, three of the deadliest and most expensive diseases facing the world today.
Growth efficiency: The new venture capital regime
Frederik Groce, Deal Lead for Wellington Access Ventures, explores how the 'growth-at-any-cost' venture capital regime has shifted to a focus on growth efficiency, highlighting two key metrics for companies to keep top of mind.
2024: a year of intensifying macro regime change?
John Butler and Eoin O’Callaghan explore why 2024 could be a year of intensifying macro regime change and what it means for investors.
The intersection of geopolitics and deglobalizationContinue reading
The US economy in 2024: A tale of transitionContinue reading
Macro implications of the AI revolution: is the market right?Continue reading
How geopolitics and the energy transition may reshape global tradeContinue reading
Commodities: Top ideas and evolving opportunitiesContinue reading